Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$2.29
-0.0600 (-2.55%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.66 $2.47 Friday, 10th May 2024 PTN stock ended at $2.29. This is 2.55% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 11.76% from a day low at $2.21 to a day high of $2.47.
90 days $1.47 $4.65
52 weeks $1.43 $5.65

Historical Palatin Technologies Inc prices

Date Open High Low Close Volume
Oct 20, 2016 $0.580 $0.580 $0.521 $0.540 914 400
Oct 19, 2016 $0.570 $0.570 $0.535 $0.541 1 076 600
Oct 18, 2016 $0.570 $0.595 $0.530 $0.595 2 246 300
Oct 17, 2016 $0.590 $0.600 $0.580 $0.583 1 010 400
Oct 14, 2016 $0.608 $0.615 $0.574 $0.596 1 321 300
Oct 13, 2016 $0.618 $0.619 $0.591 $0.595 913 500
Oct 12, 2016 $0.724 $0.724 $0.580 $0.610 1 039 400
Oct 11, 2016 $0.580 $0.620 $0.563 $0.600 1 054 000
Oct 10, 2016 $0.588 $0.600 $0.560 $0.580 1 262 200
Oct 07, 2016 $0.570 $0.580 $0.551 $0.557 917 400
Oct 06, 2016 $0.570 $0.595 $0.560 $0.570 1 270 800
Oct 05, 2016 $0.580 $0.600 $0.570 $0.575 1 046 100
Oct 04, 2016 $0.628 $0.628 $0.571 $0.586 1 453 200
Oct 03, 2016 $0.620 $0.620 $0.580 $0.607 1 737 200
Sep 30, 2016 $0.580 $0.629 $0.550 $0.629 2 463 500
Sep 29, 2016 $0.600 $0.600 $0.570 $0.580 1 290 000
Sep 28, 2016 $0.620 $0.630 $0.580 $0.590 1 513 100
Sep 27, 2016 $0.620 $0.650 $0.600 $0.631 1 629 700
Sep 26, 2016 $0.630 $0.669 $0.600 $0.619 3 068 000
Sep 23, 2016 $0.610 $0.678 $0.582 $0.652 4 157 900
Sep 22, 2016 $0.550 $0.630 $0.532 $0.600 4 220 100
Sep 21, 2016 $0.550 $0.550 $0.520 $0.550 1 445 300
Sep 20, 2016 $0.580 $0.585 $0.520 $0.530 4 760 100
Sep 19, 2016 $0.550 $0.578 $0.510 $0.557 2 214 800
Sep 16, 2016 $0.545 $0.548 $0.500 $0.502 1 686 500
Click to get the best stock tips daily for free!

About Palatin Technologies Inc

Palatin Technologies Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing oral PL8177, a selective MC1r agonist peptide that has completed Phase I clinical trial for the treatmen... PTN Profile

Golden Star

Ticker Date Change Price
PAG May 07 1.87% $153.22
WMT May 06 0.95% $59.87
UNP May 06 3.09% $239.21
JPM May 06 2.86% $192.00
ASH May 03 2.10% $95.85
INVH May 03 1.72% $34.39
INGR May 03 4.72% $114.56
VCSH May 03 0.0260% $76.93
BNDX May 03 0.205% $48.68
BBCA May 03 1.93% $65.44
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT